NCT03111329

Brief Summary

The study aims to compare routine assessment of gastric residuals versus no assessment of residuals in preterm neonates with respect to time taken for achieving full enteral feeding and the incidence of possible complications, such as feeding intolerance, necrotizing enterocolitis, sepsis etc.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2017

Completed
20 days until next milestone

First Posted

Study publicly available on registry

April 12, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

October 6, 2017

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2021

Completed
Last Updated

May 10, 2024

Status Verified

May 1, 2024

Enrollment Period

3.8 years

First QC Date

March 23, 2017

Last Update Submit

May 9, 2024

Conditions

Keywords

Gastric residuals assessmentPrematurityNecrotizing Enterocolitis of NewbornSepsis NewbornNutrition of newbornfeeding tolerance of newborn

Outcome Measures

Primary Outcomes (1)

  • Number of days taken to achieve full enteral feeding (i.e. dose of 100ml/kg/day)

    Time taken (in hours) to reach full enteral feeding, defined as overall dose of 100ml of feeds/kg of birth weight/ day

    5 days after delivery for yes or no answer to whether full enteral feeding has been achieved, thereafter daily for the first three weeks until full enteral feeding has been reached

Secondary Outcomes (11)

  • Withholding of enteral feeding

    Through first (on average) two to three weeks of the study until full enteral feeding is achieved.

  • Total duration of parenteral infusion

    Through first (on average) two to three weeks of the study until full enteral feeding is achieved.

  • Total duration of indwelling central venous catheter

    Through first (on average) two to three weeks of the study until full enteral feeding is achieved.

  • Hypoglycaemia

    Through first (on average) two to three weeks of the study until full enteral feeding is achieved.

  • Late onset sepsis

    Duration of hospitalization, an average of 8-15 weeks

  • +6 more secondary outcomes

Study Arms (2)

GRASS - Intervention group

EXPERIMENTAL

The intervention group (GRASS) will receive 3 hourly feeds, with no gastric residuals being aspirated. Solely opening of the nasogastric tube once every 6 hours to relieve possible backflow of gastric content will be allowed. Amount of enteral feeds given and increase in dose will be specified in an enteral feeding plan prior to start of the study. Amount of enteral feeds given will increase every six hours with a calculated overall increase of 20 ml/kg of birth weight in the total amount given every 24 hours. Intervention = NO aspiration of gastric residuals

Other: No aspiration of gastric residuals

Standard Approach group

NO INTERVENTION

Standard Approach group serving as control group will be treated as per standard approach - participants will be fed 3 hourly and gastric residuals checked via nasogastric tube prior to each feed. Amount of enteral feeds given and increase in dose will be specified in an enteral feeding plan prior to start of the study. Amount of enteral feeds given will increase every six hours with a calculated overall increase of 20 ml/kg of birth weight in the total amount given every 24 hours.

Interventions

No assessment of gastric residuals will be performed prior to administering 3-hourly feeds with increasing amounts of the feeds given as per a predefined plan

GRASS - Intervention group

Eligibility Criteria

Age26 Weeks - 30 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Preterm neonate, born between 26+0 and 30+0 weeks of gestation
  • Birth weight below 1500g
  • Parental informed consent obtained

You may not qualify if:

  • Intrauterine growth retardation (birth weight below 5th centile for given gestational age and gender)
  • Life-threatening events requiring full resuscitation at the delivery room (severe hypoxia, bleeding), and persistently raised lactate value of more than 5 mmol/l
  • Circulatory instability requiring treatment with inotropes
  • Highly suspected early onset sepsis with alteration of general clinical state, in particular with worsened peripheral perfusion and circulatory decompensation prior to study begin (during the first 6 hours after admission to NICU)
  • Known malformations of gastrointestinal tract, known diagnosis of congenital diaphragmatic hernia, any other life-limiting serious congenital malformations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Institute for the Care of Mother and Child

Prague, Czechia

Location

Coombe Women and Infants University Hospital

Dublin, Ireland

Location

Related Publications (1)

  • Branagan A, Murphy C, O'Sullivan A, Bodnarova I, Feyereislova S, Berka I, Miletin J, Stranak Z. Influence of gastric residual assessment in preterm neonates on time to achieve enteral feeding (the GRASS trial)-Multi-centre, assessor-blinded randomised clinical trial. Eur J Pediatr. 2024 May;183(5):2325-2332. doi: 10.1007/s00431-024-05483-w. Epub 2024 Mar 1.

MeSH Terms

Conditions

Premature BirthNeonatal Sepsis

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesSepsisInfectionsInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Zbynek Stranak, MD

    Institute for the Care of Mother and Child in Prague

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Open label during intervention, assessor of outcomes will be blinded to group allocations
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomization into 2 groups (interventional and control) with crossover rescue strategy.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2017

First Posted

April 12, 2017

Study Start

October 6, 2017

Primary Completion

July 30, 2021

Study Completion

July 30, 2021

Last Updated

May 10, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

Available on request after publication of study results

Locations